ATE409190T1 - Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel - Google Patents
Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittelInfo
- Publication number
- ATE409190T1 ATE409190T1 AT06707595T AT06707595T ATE409190T1 AT E409190 T1 ATE409190 T1 AT E409190T1 AT 06707595 T AT06707595 T AT 06707595T AT 06707595 T AT06707595 T AT 06707595T AT E409190 T1 ATE409190 T1 AT E409190T1
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- pharmaceutical products
- azole derivatives
- tricyclic azole
- tricyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05008112 | 2005-04-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE409190T1 true ATE409190T1 (de) | 2008-10-15 |
Family
ID=34935135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06707595T ATE409190T1 (de) | 2005-04-14 | 2006-03-17 | Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel |
Country Status (11)
Country | Link |
---|---|
US (1) | US20060235013A1 (de) |
EP (1) | EP1885725B1 (de) |
JP (1) | JP2008533181A (de) |
CN (1) | CN101160312A (de) |
AR (1) | AR053341A1 (de) |
AT (1) | ATE409190T1 (de) |
CA (1) | CA2602303A1 (de) |
DE (1) | DE602006002887D1 (de) |
ES (1) | ES2314879T3 (de) |
TW (1) | TW200719899A (de) |
WO (1) | WO2006108488A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008022747A1 (en) * | 2006-08-21 | 2008-02-28 | F. Hoffmann-La Roche Ag | Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
US9249147B2 (en) | 2008-03-19 | 2016-02-02 | Chembridge Corporation | Tyrosine kinase inhibitors |
CN102036990B (zh) * | 2008-03-19 | 2015-09-30 | 凯姆桥公司 | 新型酪氨酸激酶抑制剂 |
US8822500B2 (en) | 2008-03-19 | 2014-09-02 | Chembridge Corporation | Tyrosine kinase inhibitors |
US9242981B2 (en) * | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
US10435375B2 (en) * | 2015-05-05 | 2019-10-08 | Northwestern University | CXCR4 chemokine receptor modulators |
WO2021124155A1 (en) | 2019-12-20 | 2021-06-24 | Pfizer Inc. | Benzimidazole derivatives |
US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL147842B1 (en) * | 1984-05-12 | 1989-08-31 | Method of obtaining novel pyroisobenzimidazoles | |
DE3501497A1 (de) * | 1985-01-18 | 1986-07-24 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
US4835280A (en) * | 1985-01-18 | 1989-05-30 | Boehringer Mannheim Gmbh | Indoline compounds for synthesis of pharmaceutically active pyrrolobenzimidazoles |
DE3642315A1 (de) * | 1986-12-11 | 1988-06-23 | Boehringer Mannheim Gmbh | Neue pyrrolobenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel |
DE3701277A1 (de) * | 1987-01-17 | 1988-07-28 | Boehringer Mannheim Gmbh | Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel |
DE3803775A1 (de) * | 1988-02-09 | 1989-08-17 | Boehringer Mannheim Gmbh | Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |
DE4027592A1 (de) * | 1990-08-31 | 1992-03-05 | Beiersdorf Ag | Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen |
YU155791A (sh) * | 1990-09-25 | 1994-01-20 | Agouron Pharmaceuticals Inc. | Antiproliferativna supstituisana triciklična jedinjenja |
US6716575B2 (en) * | 1995-12-18 | 2004-04-06 | Sugen, Inc. | Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
EP1441725A1 (de) * | 2001-10-26 | 2004-08-04 | Aventis Pharmaceuticals Inc. | Benzimidazole und analoga und ihre verwendung als proteinkinase-hemmer |
FR2831536A1 (fr) * | 2001-10-26 | 2003-05-02 | Aventis Pharma Sa | Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr |
AR045037A1 (es) * | 2003-07-10 | 2005-10-12 | Aventis Pharma Sa | Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion. |
-
2006
- 2006-03-17 WO PCT/EP2006/002477 patent/WO2006108488A1/en active IP Right Grant
- 2006-03-17 DE DE602006002887T patent/DE602006002887D1/de not_active Expired - Fee Related
- 2006-03-17 AT AT06707595T patent/ATE409190T1/de not_active IP Right Cessation
- 2006-03-17 ES ES06707595T patent/ES2314879T3/es active Active
- 2006-03-17 EP EP06707595A patent/EP1885725B1/de not_active Not-in-force
- 2006-03-17 JP JP2008502295A patent/JP2008533181A/ja active Pending
- 2006-03-17 TW TW095109261A patent/TW200719899A/zh unknown
- 2006-03-17 CA CA002602303A patent/CA2602303A1/en not_active Abandoned
- 2006-03-17 US US11/384,058 patent/US20060235013A1/en not_active Abandoned
- 2006-03-17 CN CNA2006800124296A patent/CN101160312A/zh active Pending
- 2006-03-20 AR ARP060101077A patent/AR053341A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR053341A1 (es) | 2007-05-02 |
DE602006002887D1 (de) | 2008-11-06 |
EP1885725A1 (de) | 2008-02-13 |
CA2602303A1 (en) | 2006-10-19 |
EP1885725B1 (de) | 2008-09-24 |
ES2314879T3 (es) | 2009-03-16 |
JP2008533181A (ja) | 2008-08-21 |
CN101160312A (zh) | 2008-04-09 |
TW200719899A (en) | 2007-06-01 |
WO2006108488A8 (en) | 2008-01-10 |
US20060235013A1 (en) | 2006-10-19 |
WO2006108488A1 (en) | 2006-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE467633T1 (de) | 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung | |
DE502005002105D1 (de) | 4-benzimidazol-2-yl-pyridazin-3-on-derivative, ihre herstellung und verwendung in arzneimitteln | |
DE602006013878D1 (de) | Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel | |
DE602005006815D1 (de) | 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung | |
DE502005006424D1 (de) | Neue alkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel | |
ATE425979T1 (de) | Neue substituierte imidazo-pyridinone und imidazo-pyridazinone, ihre herstellung und ihre verwendung als arzneimittel | |
DE602005002470D1 (de) | 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung | |
DE50312295D1 (de) | 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel | |
DE602005019743D1 (de) | Oxopiperidinderivate, ihre herstellung und therapeutische verwendung | |
ATE502035T1 (de) | 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung | |
ATE538125T1 (de) | Neue 2-azaindol-derivate, deren herstellung und pharmazeutische verwendung als kinase-inhibitoren | |
ATE409190T1 (de) | Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel | |
ATE489382T1 (de) | Benzoxazinonderivate, deren herstellung und verwendung als arzneimittel | |
ATE432701T1 (de) | Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren | |
ATE472549T1 (de) | Octahydropyrroloä3,4-cüpyrrolderivate und ihre verwendung als antivirale mittel | |
ATE417846T1 (de) | Aminotropanderivate, deren herstellung und deren therapeutische verwendung | |
DE602004021384D1 (de) | Indol-5 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren | |
ATE419244T1 (de) | Neue cycloalkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel | |
ATE540023T1 (de) | Neuartige 3-aminoalkyl-1,3-dihydro-2h-indol-2-on- derivate, ihre herstellung und therapeutische verwendung | |
ATE474840T1 (de) | 6-heteroarylpyridoindolon-derivate, ihre herstellung und ihre therapeutische anwendung | |
ATE520654T1 (de) | Polypyrrol-derivate, ihre herstellung und ihre therapeutische verwendung | |
DE602004015600D1 (de) | Neue imidazolderivative, deren herstellung und deren verwendung als medikament | |
ATE491710T1 (de) | 2-substituierte phenyl-5,7-dialkyl-3,7- dihydropyrrolä2,3-dü pyrimidin-4-onderivate, deren herstellung und pharmazeutische verwendung | |
DE602006008971D1 (de) | N-ä(4,5-diphenylpyrimidin-2-yl)methylüaminderivate, deren herstellung und deren therapeutische verwendung | |
ATE411295T1 (de) | 2h- oder 3h-benzoäeüindazol-1-yl-karbamat- derivate, herstellung und therapeutische verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |